Surgery or Chemoradiation for Cervical Cancer? What Makes Each Path the Better Fit

Two leaflets sit side by side on the kitchen table. One describes a radical hysterectomy, the other a course of radiotherapy with weekly chemotherapy. She has read each twice, and the question keeps circling back: if both are meant to treat the same cancer, why is the team leaning toward one and not the other? That is the real heart of the surgery vs chemoradiation cervical cancer decision, and it deserves a clearer answer than most leaflets give.

The short version is that these are not rival treatments competing for the same patient. They are two different tools, each designed for a different picture on the scans. Stage, tumor size, lymph nodes, general health and whether a future pregnancy matters all push the choice in one direction or the other.

This explainer walks through what each path actually involves, who tends to be offered which, and why the question that worries oncologists most is not surgery or radiation, but how to avoid needing both.

Why surgery vs chemoradiation for cervical cancer is really a question about stage

The cervix is the narrow neck of tissue at the bottom of the uterus, opening into the vagina. Almost all cervical cancers begin after a persistent infection with high-risk types of human papillomavirus, or HPV, a common virus passed on through skin-to-skin contact; the World Health Organization describes this link as the cause of nearly all cases. Cancer starts in the surface lining and, if untreated, grows deeper into the cervix, then outward into the tissue beside it, the upper vagina, the lymph nodes of the pelvis and eventually the bladder or bowel.

Stage is simply a formal description of how far that journey has gone. It is worked out from a pelvic examination, a biopsy and imaging, usually an MRI of the pelvis and often a PET-CT scan, which highlights areas of active cancer anywhere in the body.

Here is the principle that organizes everything else. A surgeon can only remove what can be reached with a margin of healthy tissue around it. When a tumor is small and sitting inside the cervix, that is achievable, and surgery becomes an attractive single treatment. Once the cancer has spread into the parametrium, the band of connective tissue on either side of the cervix, or into lymph nodes, clean surgical margins become unlikely. Radiation, by contrast, treats a whole region at once, including the lymph node chains, and chemotherapy given at the same time makes cancer cells more sensitive to it.

So the decision is less about which treatment is stronger and more about which one fits the shape and reach of the disease on the day it is staged. The National Cancer Institute’s patient treatment summary sets this out stage by stage, and most national guidelines follow the same logic.

Cervical cancer treatment by stage: a plain-language map

Stages run from IA, where cancer is visible only under a microscope, to IVB, where it has spread to distant organs. The National Cancer Institute’s summary groups the main options as follows, and it is worth keeping in mind that this is a map, not a prescription; individual features shift people across these lines.

• Stage IA: microscopic disease. Options range from a cone biopsy, which removes a cone-shaped wedge of the cervix, to a simple hysterectomy, which removes the uterus and cervix without the surrounding tissue.
• Stage IB1 and IB2, some IIA1: a visible tumor up to 4 cm, confined to the cervix or the upper vagina. Radical hysterectomy with lymph node assessment is the usual surgical choice. Radiotherapy, with or without chemotherapy, is an accepted alternative, especially when anesthesia or major surgery carries extra risk.
• Stage IB3 and IIA2 onward through IVA: tumors larger than 4 cm, or cancer that has reached the parametrium, lower vagina, pelvic side wall, bladder or rectum. Chemoradiation is the standard treatment.
• Stage IVB: spread to distant sites. Systemic treatment, meaning drugs that circulate through the whole body, takes the lead, with radiation used to control symptoms.

Two details make this map easier to read. First, the 4 cm cutoff is not arbitrary: larger tumors are more likely to have reached lymph nodes and more likely to need radiation after surgery anyway, which is exactly the double treatment teams want to avoid. Second, lymph node involvement on imaging moves a person toward chemoradiation regardless of how small the cervical tumor itself looks, because the nodes are now part of the target.

Stage also sets expectations for follow-up. The NHS notes that regular checkups continue for years after treatment, whichever path is taken.

What actually happens during a radical hysterectomy

A radical hysterectomy is a bigger operation than the hysterectomy many people know from benign gynecology. The surgeon removes the uterus and cervix together with the parametrium on both sides, a cuff of the upper vagina and the lymph nodes of the pelvis. The aim is to take out the tumor with a rim of normal tissue around it in every direction, so that pathologists can confirm the edges, called margins, are clear.

The ovaries are not automatically removed. In younger people with the squamous cell type, the most common type, the ovaries can often be kept, because this cancer rarely spreads to them. That decision is discussed before the operation, since removing the ovaries triggers immediate menopause.

Lymph node assessment has become more precise. In some centers a dye or tracer is injected near the tumor so that the first node or nodes draining the cervix, the sentinel nodes, can be identified and tested. If those are clear, a full node dissection may be avoided, reducing the risk of lymphedema, the chronic swelling that follows disruption of lymph drainage.

Surgical approach matters here in a way that surprises many people. For years keyhole and robotic techniques seemed an obvious step forward because they mean smaller scars and faster early recovery. Then a large randomized trial comparing minimally invasive with open radical hysterectomy found higher recurrence rates in the minimally invasive group, and major guidelines, including the National Cancer Institute’s summary, now identify the open abdominal approach as the standard for radical hysterectomy. Smaller scars were traded for a result that mattered more.

The operation takes several hours under general anesthesia. Because the nerves that control the bladder run through the parametrium, a urinary catheter stays in afterward for longer than with a simple hysterectomy, and bladder function is checked before it is removed.

How chemoradiation for cervical cancer works, week by week

Chemoradiation means radiotherapy and chemotherapy given during the same period, deliberately. The radiation does the heavy lifting. The chemotherapy, usually a platinum-based drug given once a week, acts mainly as a sensitizer: it damages the cancer cells’ ability to repair radiation injury, so each dose of radiation does more. The NHS and the National Cancer Institute both describe this combination as the standard approach for locally advanced disease.

The course has two parts. External beam radiotherapy comes first. After a planning CT scan, during which small permanent skin marks are made so the machine lines up identically each day, treatment is delivered on weekdays, typically five days a week for around five weeks, according to the NHS. Each session lasts minutes, is painless at the time, and targets the cervix, uterus, parametrium, upper vagina and the pelvic lymph node chains. Modern planning techniques shape the beams to spare as much bowel, bladder and bone marrow as possible.

Brachytherapy follows or overlaps the final weeks. The word means short-distance radiation: a hollow applicator is placed inside the vagina and uterus, usually under sedation or anesthesia, and a radioactive source is moved through it for a planned number of minutes before being withdrawn. Because the dose falls away sharply with distance, a very high dose reaches the cervix while tissue a few centimeters away receives far less. Guidelines consider brachytherapy an essential part of treatment, not an optional extra.

Timing is monitored closely. Radiation oncologists try to avoid unplanned breaks, because tumor cells can repopulate during gaps, and the whole course is designed to be completed without interruption. Blood counts are checked each week before the chemotherapy, and kidney function is watched, since platinum drugs can strain the kidneys.

Who is usually offered surgery, and who is usually asked to wait

Surgery tends to be offered when three things line up: the tumor is small enough to remove with clear margins, imaging shows no suspicious lymph nodes, and the person is fit enough for a long operation under general anesthesia. Within that group, younger people and those who want to avoid the pelvic radiation effects on ovaries and vaginal tissue often lean toward surgery, as do people who prefer a single, defined event over a multi-week course.

Chemoradiation is the usual recommendation when the tumor is larger than 4 cm, has grown into the parametrium, or lymph nodes look involved on PET-CT. It is also the sensible path when heart, lung or kidney disease makes major surgery hazardous, or when prior abdominal operations have left dense scar tissue. Radiation does not require anesthesia, and most people continue living at home throughout.

Then there is a group asked, in effect, to wait. Sometimes this means waiting for more information: a borderline node on MRI may prompt a PET-CT, or a tiny node may be biopsied before the final plan is made. Sometimes it means the surgeon plans to look at the pelvic nodes first and will stop the operation if cancer is found in them, converting the plan to chemoradiation rather than proceeding with a hysterectomy that would need radiation anyway.

A less common form of waiting is chemotherapy given before surgery to shrink a tumor, known as neoadjuvant treatment. Evidence for this is mixed, and the National Cancer Institute’s summary treats it as an option under evaluation rather than a routine standard. Pregnancy adds another layer, with timing often shaped by how far along the pregnancy is.

Every one of these judgments belongs to a multidisciplinary tumor board, where surgeons, radiation oncologists, radiologists and pathologists review the same scans together.

Radical hysterectomy vs radiation: surgery vs chemoradiation for cervical cancer at a glance

Seeing the two paths side by side helps many people understand why their team is recommending one over the other. The table below summarizes typical features drawn from NHS, Mayo Clinic and National Cancer Institute patient information. It is a general guide, not a description of any one person’s plan.

Feature	Radical hysterectomy	Chemoradiation
Typical stage	Small tumors confined to cervix (IA–IB2, some IIA1)	Larger tumors or spread beyond cervix (IB3, IIA2–IVA); nodes involved
What is treated	Uterus, cervix, parametrium, upper vagina, pelvic nodes removed	Same region treated in place, plus node chains, without removal
Duration	One operation of several hours; hospital stay of days	Around five weeks of weekday external radiation plus brachytherapy sessions, with weekly chemotherapy
Anesthesia	General anesthesia for the operation	Usually only for brachytherapy applicator placement
Ovaries	Can often be preserved	Pelvic radiation typically ends ovarian function
Fertility	Lost after hysterectomy; preserved only with trachelectomy or cone biopsy in very early disease	Lost
Common early effects	Pain, bladder retraining, fatigue, wound healing, clot risk	Fatigue, diarrhea, bladder irritation, nausea on chemotherapy days, low blood counts
Common later effects	Bladder changes, lymphedema, shortened vagina	Vaginal narrowing and dryness, bowel and bladder changes, menopause
Tissue for pathology	Yes; the full specimen is examined	No; response is judged on examination and imaging

Two rows deserve emphasis. The pathology row explains why surgery sometimes leads to a second treatment: only after the specimen is examined does the team know whether margins, nodes or parametrium were involved. The ovaries row explains why age and hormonal health weigh so heavily for younger patients, and why ovarian transposition, moving the ovaries out of the radiation field before treatment, may be discussed.

Why doctors try hard to avoid giving you both

It would seem logical that more treatment means more protection. In cervical cancer, the evidence points the other way, and this single idea explains most of the decisions patients find puzzling.

After a radical hysterectomy, the pathology report may reveal findings that raise the risk of recurrence: cancer in lymph nodes, cancer at the cut edge of the specimen, or spread into the parametrium that was not visible beforehand. Guidelines then recommend adjuvant chemoradiation, meaning treatment added after surgery to reduce that risk. A combination of intermediate findings, such as a large tumor with deep invasion and cancer cells inside small vessels, can also lead to a recommendation for radiation afterward.

The problem is that pelvic radiation on top of pelvic surgery compounds side effects. Surgery has already disturbed the lymph drainage, the bladder nerves and the bowel’s position; radiation then injures the same tissues. Lymphedema, bowel strictures, bladder dysfunction and fistulas, abnormal passages between organs, are all more common after combined treatment than after either alone. Meanwhile, trials comparing surgery followed by radiation against radiation alone for similar tumors have not shown a clear advantage for the combination.

This is why pretreatment imaging has become so central. The National Cancer Institute’s summary describes MRI as useful for judging tumor size and parametrial extension and PET-CT for detecting node involvement. If those scans suggest a high chance of needing radiation afterward, most teams will recommend chemoradiation from the start and skip the operation entirely.

It also explains the intraoperative decision mentioned earlier: a surgeon who finds involved nodes may stop and refer for chemoradiation rather than complete the hysterectomy. That can feel like an operation that failed. In fact, it is the plan working exactly as intended.

Fertility sparing cervical cancer surgery: when the womb can be kept

For someone who hopes to carry a pregnancy, the standard options are hard to hear, because both a hysterectomy and pelvic radiation end the possibility. There is, however, a narrower path for very early disease, and it should be raised before any treatment begins, not after.

Fertility-sparing surgery means removing the cancer while leaving the uterus in place. For microscopic stage IA disease, a cone biopsy or a slightly wider local excision may be sufficient on its own. For small visible tumors, generally those measuring up to 2 cm with no node involvement, the operation is a trachelectomy: removal of the cervix, the upper vagina and, in the radical version, the parametrium, with the uterus reconnected to the vagina. A permanent stitch, called a cerclage, is usually placed where the cervix used to be to help support a future pregnancy. Pelvic lymph nodes are assessed in the same way as in a hysterectomy, and the National Cancer Institute lists trachelectomy among the standard options for selected early-stage patients.

Pregnancies after trachelectomy are possible but are considered higher risk, with increased rates of late miscarriage and preterm birth, and they are managed by specialist obstetric teams, usually with delivery by cesarean section. The NHS flags this as something to discuss with the care team beforehand.

When the stage rules out fertility-sparing surgery, two separate conversations are worth having. Egg or embryo freezing before treatment preserves the option of a biological child carried by a surrogate, where that is legal and acceptable to the person. Ovarian transposition before radiation can protect hormone production, reducing the chance of early menopause, although it does not preserve the ability to carry a pregnancy and does not always succeed, since scattered radiation still reaches the moved ovaries in some cases.

What the following weeks usually look like after surgery

The first days after a radical hysterectomy are spent in hospital. Pain is managed with a planned combination of medicines, and the team will want you walking within a day, partly to protect the lungs and partly to lower the risk of blood clots in the legs, which is raised after pelvic surgery for cancer. Compression stockings and blood-thinning injections are common during this period, and some people continue clot prevention for a few weeks at home; the length is set by the surgical team.

The bladder deserves its own paragraph. Because nerves to the bladder run through the removed parametrium, many people cannot sense fullness or empty completely at first. A catheter typically stays in longer than after a simple hysterectomy, sometimes into the second week, and before it comes out the team checks how much urine remains after voiding. A minority need intermittent self-catheterization for a while. Most bladder function returns over weeks to months, though some people notice lasting changes in sensation.

At home, the NHS advises that recovery from an abdominal hysterectomy generally takes around 6–12 weeks, with heavy lifting, driving and sexual intercourse resumed only on the surgeon’s advice. Tiredness out of proportion to activity is normal in this window. A small amount of vaginal spotting or discharge is expected as the top of the vagina heals.

The pathology report usually arrives within a couple of weeks and prompts the single most important post-operative appointment. If margins, nodes and parametrium are clear, follow-up begins. If not, the conversation turns to adjuvant chemoradiation, usually starting once wounds have healed. Either way, the first follow-up examinations are typically every few months in the early years, according to the NHS, and the schedule lengthens over time.

What the following weeks usually look like during and after chemoradiation

Chemoradiation unfolds slowly, and its side effects are cumulative rather than immediate. The first week often feels anticlimactic: a few minutes on the treatment table each day, a chemotherapy infusion lasting a few hours once a week, and little else. By the third and fourth weeks the picture changes.

Fatigue builds steadily and is the symptom people most often underestimate. Bowel changes follow, because the small bowel and rectum sit inside the treated region; loose stools, urgency and cramping are common, and dietary adjustments and anti-diarrheal medicines prescribed by the team usually control them. Bladder irritation produces frequency and stinging similar to a urine infection, and the team will test urine to tell the two apart. Skin in the groin and buttock creases can redden and peel. On chemotherapy days, nausea is the main concern, and anti-sickness medicines are given in advance. Blood counts fall gradually, which is why they are checked before each infusion; a low count may mean a chemotherapy dose is held while radiation continues.

Brachytherapy sessions add short hospital visits with sedation or anesthesia and some pelvic cramping afterward. Once the course ends, acute symptoms usually peak over the following one to two weeks and then ease over several weeks, although the Mayo Clinic notes that fatigue can persist for months.

The first response assessment generally takes place about three months after completion, often with a PET-CT or MRI, because tissue needs time to settle before imaging is reliable. From the end of treatment onward, vaginal dilators are introduced to keep the vaginal canal open and allow comfortable examinations, a topic the next section covers in more detail. Late effects on bowel and bladder can appear months or years later, which is one reason follow-up continues long after the treatment itself.

Sex, menopause and body changes: the conversation worth having early

Few topics are raised less often in clinic and matter more afterward. Both treatments change the pelvis, and knowing what to expect turns surprises into manageable problems.

Menopause is the sharpest difference between the paths. Radiation to the pelvis typically stops the ovaries from working within weeks, bringing on hot flashes, night sweats, sleep disruption and vaginal dryness in people who had not yet reached menopause. Surgery that preserves the ovaries avoids this. For those who do experience treatment-induced menopause, hormone replacement therapy is often discussed, since cervical cancer is not usually hormone-driven; whether it is appropriate is an individual decision for the treating team, weighing age, cancer type and other health conditions.

Vaginal changes differ too. A radical hysterectomy removes a cuff of the upper vagina, so it is shorter afterward, which some people notice during deep penetration. Radiation leaves the vagina intact but causes the walls to become thinner, drier and less elastic, and scar tissue can narrow or shorten it, a process called stenosis. Regular use of vaginal dilators, graded smooth cylinders used with lubricant several times a week, is recommended by the NHS after radiotherapy to limit this. Water-based lubricants and vaginal moisturizers help with dryness after either treatment.

Lymphedema can follow lymph node removal or radiation, appearing as swelling of one or both legs or the lower abdomen, sometimes years later. Early referral to a lymphedema specialist for compression and exercise guidance makes a real difference to comfort.

Desire itself often falls during treatment and recovers slowly. Fatigue, body image, fear of pain and the emotional weight of a cancer diagnosis all contribute. Psychosexual counseling is available through many cancer services, and partners are usually welcome to attend.

What people often get wrong about surgery vs chemoradiation for cervical cancer

“Surgery is better because it physically removes the cancer.” Removing a tumor feels definitive, yet for locally advanced disease a scalpel cannot reliably reach every cell in the parametrium and nodes, whereas radiation treats the whole region. For tumors matched to the right stage, guidelines regard the two approaches as comparably effective, which is exactly why stage, not instinct, drives the choice.

“Radiation is what they offer when it is too late for surgery.” Chemoradiation is the standard first-line treatment for stage IB3 through IVA disease, given with the intent of eliminating the cancer. It is not a consolation prize.

“Chemo here is like chemo for other cancers.” In chemoradiation the chemotherapy is given weekly in a sensitizing role, and hair loss is uncommon with the platinum drug typically used. The experience differs substantially from multi-cycle chemotherapy for other diseases.

“Keyhole surgery is always the modern choice.” For radical hysterectomy specifically, a randomized trial found worse cancer outcomes with minimally invasive approaches, and open surgery is the current standard. Smaller scars are not the point.

“Having both treatments doubles my protection.” Combined treatment increases complications without clear added benefit, which is why teams work to pick one path from the outset.

“Once treated, HPV and screening are behind me.” Follow-up examinations continue for years. People who keep their cervix after a trachelectomy or cone biopsy still need surveillance of the remaining tissue, and the Centers for Disease Control and Prevention notes that HPV infection can persist.

“Surgery guarantees I can still have children.” Only fertility-sparing procedures preserve the uterus, and only in selected very early cases. A radical hysterectomy ends fertility just as radiation does.

Questions to ask your care team

A tumor board meeting produces a recommendation; the conversation afterward turns it into a plan you understand. Bringing written questions helps, and so does bringing someone to take notes. These are the questions that tend to unlock the clearest answers.

• What is my exact stage, and which findings on the MRI or PET-CT most influenced your recommendation?
• Based on my scans, how likely is it that I would need radiation after surgery? Is that the reason you are suggesting chemoradiation up front, or vice versa?
• If surgery is planned, will the lymph nodes be examined during the operation, and what happens if cancer is found in them?
• Is sentinel node mapping available for me, and would it reduce my lymphedema risk?
• Can my ovaries be preserved? If radiation is planned, is ovarian transposition an option worth discussing?
• Am I a candidate for fertility-sparing surgery? If not, can I see a fertility specialist before treatment begins?
• For chemoradiation, how many external beam sessions and brachytherapy sessions are planned, and what is the target completion date?
• Which side effects are you most watching for in my case, given my other health conditions?
• Who do I call out of hours if I develop a fever or heavy bleeding, and what number should be on my fridge?
• What will my follow-up schedule look like in the first year, and what imaging will be used?
• Are there clinical trials I should know about, including newer approaches such as adding immune checkpoint inhibitors for higher-risk locally advanced disease?
• Who on the team can talk with me about sexual health, menopause and emotional support?

No question on this list is too basic. Teams expect them, and answers that are hard to follow should prompt a request to go through it again. A second opinion is a reasonable request for a decision of this size, and most oncologists will support it.

When to call your doctor

Both treatment paths come with a 24-hour contact number, and the single most useful habit is to use it early rather than wait for a morning appointment. Cancer services would far rather hear about a symptom that turns out to be nothing than miss one that is not.

Call the same day, or seek urgent care, for any of the following during or after surgery: a temperature of 38°C (100.4°F) or higher; bleeding that soaks a pad in an hour or passes large clots; redness, spreading warmth, opening or foul-smelling discharge at the wound; inability to pass urine or sudden severe pain over the bladder; pain, swelling or warmth in one calf; or a new cough, chest pain or breathlessness, which can signal a clot that has traveled to the lungs.

During chemoradiation, treat any fever as an emergency even if you feel reasonably well, because chemotherapy can lower the infection-fighting white cells and a fever may be the only early sign of a serious infection. Call urgently for diarrhea that persists despite prescribed medicines or comes with dizziness and reduced urine output, vomiting that prevents fluids staying down for more than a few hours, blood in the stool or urine, severe abdominal pain, or any new confusion or drowsiness.

In the months and years that follow, new or worsening vaginal bleeding after intercourse, persistent pelvic or back pain, leg swelling, or leakage of urine or stool from the vagina should all be reported promptly rather than left for the next scheduled visit.

Emotional distress counts too. Persistent low mood, anxiety that interferes with daily life or thoughts of self-harm deserve the same prompt call. Every one of these decisions, from the treatment chosen to how a symptom is managed, rests with your treating team, who know your history and your scans.

Frequently asked questions

Is surgery or chemoradiation more effective for cervical cancer?

Neither is more effective across the board; each is the standard for a different stage. For small tumors confined to the cervix, surgery and radiation are considered comparable options by major guidelines, and the choice depends on side-effect profiles, fitness and preferences. For larger tumors or spread into surrounding tissue or lymph nodes, chemoradiation is the recommended first treatment because surgery cannot reliably clear the disease.

Why did my team recommend chemoradiation for cervical cancer instead of removing the tumor?

Most often because imaging suggests a high chance that surgery would need to be followed by radiation anyway, for example a tumor larger than 4 cm, involvement of the tissue beside the cervix, or suspicious lymph nodes. Since combining both treatments raises complication rates without clear added benefit, guidelines favor going straight to chemoradiation in these situations. Ask your team which scan findings drove the recommendation.

What is the difference between a radical hysterectomy vs radiation in terms of side effects?

Surgery brings a short, intense recovery with wound healing, bladder retraining, clot risk and a chance of lymphedema, while usually preserving ovarian function. Radiation spreads side effects over weeks, mainly fatigue, diarrhea and bladder irritation, and typically causes menopause in people who have not yet reached it, along with vaginal dryness and narrowing that dilators help limit. Both can affect sexual function and bowel or bladder habits long term.

How is cervical cancer treatment by stage decided?

Staging combines a pelvic examination, biopsy results and imaging, usually MRI and often PET-CT, to describe tumor size, spread into neighboring tissue and lymph node involvement. A multidisciplinary tumor board reviews these together. Microscopic and small confined tumors are usually directed toward surgery, larger or locally spread tumors toward chemoradiation, and distant spread toward drug treatment, with individual health factors adjusting the plan.

Can I have fertility sparing cervical cancer surgery?

Possibly, if the cancer is at a very early stage, generally a tumor up to 2 cm confined to the cervix with no lymph node involvement. Options include a cone biopsy for microscopic disease or a trachelectomy, which removes the cervix but keeps the uterus. Later pregnancies carry higher risks of preterm birth and need specialist care. Raise fertility before any treatment starts so referrals can happen in time.

Will I lose my hair during chemoradiation for cervical cancer?

Usually not. The chemotherapy in chemoradiation is a platinum-based drug given weekly in a sensitizing role, and significant hair loss is uncommon with it, unlike some multi-drug regimens used for other cancers. The more typical effects are nausea on infusion days, fatigue, lowered blood counts and strain on the kidneys, all of which your team monitors with weekly blood tests before each dose.

Why is open surgery recommended instead of keyhole for radical hysterectomy?

A large randomized trial comparing minimally invasive with open radical hysterectomy found higher recurrence rates in the minimally invasive group, which led major guidelines to name the open abdominal approach as the standard for this specific operation. The reasons are still being studied, with tumor handling and gas insufflation among the theories. Keyhole techniques remain appropriate for many other gynecologic operations.

What happens if cancer is found in my lymph nodes during surgery?

Many surgeons will stop the operation at that point rather than complete the hysterectomy, and refer you for chemoradiation instead. This is a planned response, not a failure: completing the hysterectomy and then adding radiation would expose you to the combined side effects of both treatments without a clear benefit. The plan should be discussed and agreed with you before the operation.

How long does recovery take after surgery vs chemoradiation?

After an abdominal hysterectomy the NHS describes recovery as generally taking around 6–12 weeks, with bladder function sometimes taking longer to settle. Chemoradiation itself lasts around five weeks of external treatment plus brachytherapy; acute side effects usually peak within a couple of weeks of finishing and ease over the following weeks, though fatigue may persist for months. Your team will give timelines specific to you.

Can I still get cervical cancer again after treatment?

Recurrence is possible after either treatment, which is why follow-up examinations continue for several years and are more frequent early on. People who kept their cervix after a cone biopsy or trachelectomy also need ongoing surveillance of the remaining tissue, since persistent HPV infection can cause new changes. Report new bleeding, pelvic pain or leg swelling between visits rather than waiting.

References

• NHS: Cervical cancer, treatment
• World Health Organization: Cervical cancer fact sheet
• NHS: Hysterectomy, recovery
• MedlinePlus: Cervical cancer

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.